Oligoclonal CD4 + CXCR5 + T cells with a cytotoxic phenotype appear in tonsils and blood.
Autor: | Liang C; Functional Genomics and Systems Biology Group, Department of Bioinformatics, Biocenter, Julius-Maximilians-University Würzburg, Würzburg, Germany.; Institute of Immunology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany., Spoerl S; Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Xiao Y; Institute of Pathology, Julius-Maximilians-University Würzburg, Würzburg, Germany., Habenicht KM; Division of Genetics, Department Biology, Nikolaus-Fiebiger-Center of Molecular Medicine, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Haeusl SS; Institute of Pathology, Julius-Maximilians-University Würzburg, Würzburg, Germany., Sandner I; Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Winkler J; Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Strieder N; Leibniz Institute for Immunotherapy, Regensburg, Germany., Eder R; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Stanewsky H; Leibniz Institute for Immunotherapy, Regensburg, Germany., Alexiou C; Department of Otorhinolaryngology, Head & Neck Surgery, Else Kröner-Fresenius-Foundation-Professorship, Section of Experimental Oncology & Nanomedicine (SEON), University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Dudziak D; Laboratory of Dendritic Cell Biology, Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.; Institute of Immunology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany., Rosenwald A; Institute of Pathology, Julius-Maximilians-University Würzburg, Würzburg, Germany.; Comprehensive Cancer Centre Mainfranken, Julius-Maximilians-University of Würzburg, Würzburg, Germany., Edinger M; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Rehli M; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Hoffmann P; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Winkler TH; Division of Genetics, Department Biology, Nikolaus-Fiebiger-Center of Molecular Medicine, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Berberich-Siebelt F; Institute of Pathology, Julius-Maximilians-University Würzburg, Würzburg, Germany. path230@mail.uni-wuerzburg.de. |
---|---|
Jazyk: | angličtina |
Zdroj: | Communications biology [Commun Biol] 2024 Jul 18; Vol. 7 (1), pp. 879. Date of Electronic Publication: 2024 Jul 18. |
DOI: | 10.1038/s42003-024-06563-1 |
Abstrakt: | In clinical situations, peripheral blood accessible CD3 + CD4 + CXCR5 + T-follicular helper (T (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |